Primary Aspergillus spondylodiscitis in a liver transplant recipient

Xin-Feng Li1, Zu-de Liu, Qiang Xia

  • 1Department of Orthopaedic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Chinese Medical Journal
|August 31, 2012
PubMed

Insights

Primary Aspergillus flavus spondylodiscitis is a rare complication in liver transplant recipients. This case highlights successful treatment with debridement and voriconazole, even without fever or elevated white blood cell count.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Mycology

Background:

  • Solid organ transplant recipients face heightened risks of Aspergillus infections.
  • Aspergillus spondylodiscitis is uncommon, typically arising from invasive pulmonary disease spread.
  • Primary spinal infection without pulmonary involvement is exceptionally rare.

Observation:

  • A liver transplant recipient presented with chronic lumbar back pain six months post-transplant.
  • The patient lacked fever and had normal white blood cell counts.
  • Elevated plasma (1→3)-beta-d-glucan (BDG) levels correlated with back pain.

Findings:

  • The causative agent was identified as Aspergillus flavus.
  • The infection was diagnosed as primary spondylodiscitis.
  • Clinical and radiological recovery was achieved.

Implications:

  • This case demonstrates that Aspergillus spondylodiscitis can occur primarily in the spine in transplant patients.
  • Prompt diagnosis using markers like BDG is crucial.
  • Effective treatment involves surgical debridement and antifungal therapy (voriconazole).